Empiric Use of Trimethoprim‐Sulfamethoxazole (TMP‐SMX) in the Treatment of Women with Uncomplicated Urinary Tract Infections, in a Geographical Area with a High Prevalence of TMP‐SMX–Resistant Uropathogens

This publication has 10 references indexed in Scilit:

• Resistance of bacteria in urinary tract infections
  International Journal of Antimicrobial Agents, 2000
• Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in Women
  JAMA, 2000
• Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women
  Clinical Infectious Diseases, 1999
• A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women
  The American Journal of Medicine, 1999
• Increasing Prevalence of Antimicrobial Resistance Among Uropathogens Causing Acute Uncomplicated Cystitis in Women
  JAMA, 1999
• Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991–1995
  European Journal of Clinical Microbiology & Infectious Diseases, 1997
• Trimethoprim and sulfonamide resistance
  Antimicrobial Agents and Chemotherapy, 1995
• Trimethoprim resistance
  Antimicrobial Agents and Chemotherapy, 1987
• The Changing Pattern of Trimethoprim Resistance in Paris, with a Review of Worldwide Experience
  Clinical Infectious Diseases, 1986
• Increasing Resistance to Trimethoprim-Sulfamethoxazole Among Isolates of Escherichia coli in Developing Countries
  The Journal of Infectious Diseases, 1985